Mrv1652306231722432D 18 13 0 0 0 0 999 V2000 0.8793 2.0308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8793 1.2058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.5938 0.7933 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.1649 0.7933 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.1649 -0.0317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8793 -0.4442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8793 -1.2692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.1649 -1.6817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.5496 -1.2692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.5496 -0.4442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.2641 -0.0317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.2641 0.7933 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.9785 -0.4442 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 4.8938 0.0000 0.0000 O 0 6 0 0 0 0 0 0 0 0 0 0 0.4125 -3.3317 0.0000 O 0 6 0 0 0 0 0 0 0 0 0 0 2.7696 -3.3317 0.0000 O 0 6 0 0 0 0 0 0 0 0 0 0 4.0688 0.0000 0.0000 Al 0 1 0 0 0 0 0 0 0 0 0 0 -0.4125 -3.3317 0.0000 Al 0 1 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 2 0 0 0 0 2 4 1 0 0 0 0 4 5 1 0 0 0 0 5 6 2 0 0 0 0 6 7 1 0 0 0 0 7 8 2 0 0 0 0 8 9 1 0 0 0 0 9 10 2 0 0 0 0 5 10 1 0 0 0 0 10 11 1 0 0 0 0 11 12 2 0 0 0 0 11 13 1 0 0 0 0 M CHG 5 14 -2 15 -2 16 -2 17 3 18 3 M END > DB13509 > drugbank > [O--].[O--].[O--].[Al+3].[Al+3].CC(=O)OC1=CC=CC=C1C(O)=O > InChI=1S/C9H8O4.2Al.3O/c1-6(10)13-8-5-3-2-4-7(8)9(11)12;;;;;/h2-5H,1H3,(H,11,12);;;;;/q;2*+3;3*-2 > MXCPYJZDGPQDRA-UHFFFAOYSA-N > C9H8Al2O7 > 282.119 > 281.9900796 > 3 > 26 > 16.957021169355837 > 1 > 1 > 0 > 1 > dialuminium(3+) ion 2-(acetyloxy)benzoic acid trioxidandiide > 1.19 > 1.238089698333333 > -0.76 > 0 > 1 > -1 > 3.4147992082888363 > -7.144798751338897 > 63.60000000000001 > 44.446600000000004 > 3 > 1 > 3.62e+01 g/l > dialuminium(3+) ion aspirin trioxidandiide > 0 > DB13509 > experimental > Aloxiprin > Aloxiprin $$$$